GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bright Green Corp (OTCPK:BGXX) » Definitions » 3-Year RORE %

BGXX (Bright Green) 3-Year RORE % : -26.32% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bright Green 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Bright Green's 3-Year RORE % for the quarter that ended in Jun. 2024 was -26.32%.

The industry rank for Bright Green's 3-Year RORE % or its related term are showing as below:

BGXX's 3-Year RORE % is ranked worse than
71.65% of 970 companies
in the Drug Manufacturers industry
Industry Median: -0.625 vs BGXX: -26.32

Bright Green 3-Year RORE % Historical Data

The historical data trend for Bright Green's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Green 3-Year RORE % Chart

Bright Green Annual Data
Trend Dec20 Dec21 Dec22 Dec23
3-Year RORE %
- - - 23.62

Bright Green Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 20.75 23.62 18.71 -26.32

Competitive Comparison of Bright Green's 3-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, Bright Green's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bright Green's 3-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bright Green's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Bright Green's 3-Year RORE % falls into.



Bright Green 3-Year RORE % Calculation

Bright Green's 3-Year RORE % for the quarter that ended in Jun. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.06--0.135 )/( -0.285-0 )
=0.075/-0.285
=-26.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2024 and 3-year before.


Bright Green  (OTCPK:BGXX) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Bright Green 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Bright Green's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bright Green Business Description

Traded in Other Exchanges
N/A
Address
1033 George Hanosh Boulevard, Grants, NM, USA, 87020
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).
Executives
Saleem Elmasri officer: Chief Financial Officer 450 PARK AVE SOUTH, 3RD FLOOR, NEW YORK NY 10016
Lynn Stockwell director, 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Gurvinder Singh officer: Chief Executive Officer 1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Seamus Mcauley officer: Chief Executive Officer 1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Edward A. Robinson director, officer: Chief Executive Officer 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Alfie Morgan director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Dean Vallore director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Terry Rafih director, 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Robert Arnone director 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
E. Mailloux Enterprises, Inc. 10 percent owner 3129 MARENTETTE AVENUE, UNIT 2, WINDSOR A6 N8X 4G1

Bright Green Headlines

From GuruFocus

SABBY MANAGEMENT, LLC Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-17-2023